Stigma of Mental Illness in China: Extending the SGC-MHS

描述(由调查人员提供)：根据美国卫生局局长和世界卫生组织(WHO)的说法，与精神疾病(MI)相关的耻辱是识别、治疗和康复的最关键障碍之一。在Fogarty国际中心的一项特别计划下，在国家精神健康研究所和行为和社会科学研究办公室的额外支持下，开展了全球背景下的耻辱-精神健康研究(SGC-MHS)，以了解各国对MI的理解和耻辱的程度。尽管包括了广泛的国家，中国在SGC-MHS数据集中是一个值得注意的缺席。此应用程序旨在通过将中国的丰富专业知识及其独特的采样挑战与SGC-MHS研究人员的经验相结合来填补这一空白。这项申请建议：1)使用定制版本的SGC-MH研究工具估计中国耻辱的性质、水平和个人水平；2)使用SGC-MHS中文模块收集的调查数据来检验关于障碍，特别是耻辱对医疗和心理健康服务认可的影响的假设；3)将SGC-MHS中文模块的数据整合到更大的16个国家的研究中，以检验耻辱的原因和相关性。为此，将使用定制版本的SGCMHS工具，从具有全国代表性的中国人口样本(N=5250)中进行面对面访谈，收集数据。将中国纳入SGC-MHS将提高对耻辱根源的理解，提高对全球耻辱负担的估计，并为中国和其他地方减少耻辱提供关键的科学基础。 与公共卫生相关：中国拥有世界五分之一的人口，在包括精神疾病在内的全球疾病负担中占有相当大的份额。现有研究表明，污名既塑造了个人问题(例如，服务使用率低、偏见、歧视)，也塑造了系统问题(例如，治疗资源不足)。研究中国对态度、信念和行为倾向进行污名化的根源和潜在后果，将大大提高对科学的理解、干预措施的发展以及SGC-MHS现有的跨国合作提供的数据的政策含义。

DESCRIPTION (provided by investigator): According to the U.S. Surgeon General and the World Health Organization (WHO), the stigma attached to mental illness (MI) stands as one of the most critical barriers to recognition, treatment and recovery. Under a special program of the Fogarty International Center and with additional support from the National Institute of Mental Health and the Office of Behavioral and Social Science Research, the Stigma in Global Context - Mental Health Study (SGC-MHS) was mounted to understand the extent to which MI is understood and stigmatized across countries. Despite the inclusion of a wide range of countries, China stands as a notable absence in the SGC-MHS data set. This application is designed to fill that gap by combining substantive expertise on China and its unique sampling challenges with the experience of SGC-MHS researchers. This application proposes to : 1) Estimate the nature, level and individual level correlates of stigma in China using a tailored version of the SGC-MH Study instrument; 2) Use the survey data collected by the Chinese module of the SGC-MHS to test hypotheses concerning the influences of barriers, particularly stigma, to the endorsement of medical and mental health services; 3) Integrate the data from the Chinese module of the SGC-MHS into the larger 16 nation study to examine the causes and correlates of stigma. Towards these ends, data will be collected from a nationally representative sample of the Chinese population (N= 5,250) in face-to-face interviews using a tailored version of the SGCMHS instrument. Adding China to the SGC-MHS will improve understanding of the underlying roots of stigma, sharpen estimates of the global burden of stigma, and provide a critical, scientific base for stigma reduction in China and elsewhere. PUBLIC HEALTH RELEVANCE: With one-fifth of the world's population, China accounts for a sizable share of the global burden of disease, including mental illness. Existing research indicates that stigma shapes both individual (e.g., low service use, prejudice, discrimination) and system problems (e.g., inadequate treatment resources). Examining both the roots and the potential consequences of stigmatizing attitudes, beliefs, and behavioral predispositions in China would significantly improve scientific understanding, the development of interventions and the policy implications of data provided by the existing cross-national collaboration in the SGC-MHS.